Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Addera Cal is a combination nutritional supplement developed by Mantecorp Saúde, a division of Hypera Pharma, primarily indicated for the maintenance of bone health and the prevention or treatment of calcium and vitamin D deficiencies. The formulation contains calcium citrate malate, a highly bioavailable form of calcium that is well-absorbed even in the absence of gastric acid, and cholecalciferol (vitamin D3). Vitamin D3 is essential for the active absorption of calcium from the gastrointestinal tract and for maintaining adequate serum calcium and phosphate concentrations to enable normal mineralization of bone. The product is widely used in Brazil for the prevention and treatment of osteoporosis and osteopenia, particularly in populations at risk for bone density loss.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium citrate malate + cholecalciferol (Mantecorp Saúde).